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Common variations at the loci harboring the fat mass and obesity gene (FTO), MC4R, and
TMEM18 are consistently reported as being associated with obesity and body mass index
(BMI) especially in adult population. In order to conﬁrm this effect in pediatric population
ﬁve European ancestry cohorts from pediatric eMERGE-II network (CCHMC-BCH) were
evaluated.
Method: Data on 5049 samples of European ancestry were obtained from the Electronic
Medical Records (EMRs) of two large academic centers in ﬁve different genotyped cohorts.
For all available samples, gender, age, height, and weight were collected and BMI was cal-
culated.To account for age and sex differences in BMI, BMI z -scores were generated using
2000 Centers of Disease Control and Prevention (CDC) growth charts. A Genome-wide
association study (GWAS) was performed with BMI z -score. After removing missing data
and outliers based on principal components (PC) analyses, 2860 samples were used for
the GWAS study. The association between each single nucleotide polymorphism (SNP)
and BMI was tested using linear regression adjusting for age, gender, and PC by cohort.
The effects of SNPs were modeled assuming additive, recessive, and dominant effects of
the minor allele. Meta-analysis was conducted using a weighted z -score approach.
Results: The mean age of subjects was 9.8 years (range 2–19). The proportion of male
subjects was 56%. In these cohorts, 14% of samples had a BMI ≥95 and 28 ≥ 85%. Meta
analyses produced a signal at 16q12 genomic region with the best result of p = 1.43 × 10−7
[p 8(rec) = 7.34 × 10− ) for the SNP rs8050136 at the ﬁrst intron of FTO gene (z = 5.26)
and with no heterogeneity between cohorts (p = 0.77). Under a recessive model, another
published SNP at this locus, rs1421085, generates the best result [z 5.782, p(rec)
8.21 × 10−9
= =
]. Imputation in this region using dense 1000-Genome and Hapmap CEU
samples revealed 71 SNPs with p < 10−6, all at the ﬁrst intron of FTO locus.When hetero-
geneity was permitted between cohorts, signals were also obtained in other previously
identiﬁed loci, including MC4R (rs12964056, p = 6.87 × 10−7, z = −4.98), cholecystokinin
CCK (rs8192472, p = 1.33 × 10−6, z = −4.85), Interleukin 15 (rs2099884, p = 1.27 × 10−5,
z = 4.34), low density lipoprotein receptor-related protein 1B [LRP1B (rs7583748,
p = 0.00013, z = −3.81)] and near transmembrane protein 18 (TMEM18) (rs7561317,
p = 0.001, z = −3.17).We also detected a novel locus at chromosome 3 at COL6A5 [best
SNP = rs1542829, minor allele frequency (MAF) of 5% p = 4.35 × 10−9, z = 5.89].
Conclusion: An EMR linked cohort study demonstrates that the BMI-Z measurements
can be successfully extracted and linked to genomic data with meaningful conﬁrmatory
results. We veriﬁed the high prevalence of childhood rate of overweight and obesity in
our cohort (28%). In addition, our data indicate that genetic variants in the ﬁrst intron of
FTO, a known adult genetic risk factor for BMI, are also robustly associated with BMI in
pediatric population.
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INTRODUCTION
The electronic MEdical Records and GEnomics (eMERGE) Net-
work, founded in 2007, is a consortium of multiple adult and
pediatric institutions developed to explore the utility of DNA bio
repositories linked to electronicmedical records (EMR) in advanc-
ing genomic medicine (McCarty et al., 2011). For each site, the
primary site-speciﬁc phenotypes have undergone genome-wide
association studies (GWAS) with data and results shared through
the network. In the pediatric population, however, genetic studies
are challenging due to different developmental phase and growth
patterns, different spectrums of disease, and unusual rare genetic
or congenital abnormalities.
In both adults and children, obesity is a major risk factor for
a number of chronic diseases, a steady and continuous rise in
prevalence over the past four decades holds serious and ominous
medical and economic burdens (Kopelman, 2000). The pheno-
type is highly heritable. Family and twin studies have shown that
between 40 and 70% of the inter-individual variation in obesity
can be attributable to genetic factors (Maes et al., 1997). In recent
years, large-scale GWAS have identiﬁed many loci associated with
Body Mass Index (BMI), the most common measure of obesity,
but these loci combined explain only 2–4% of the heritability
(Speliotes et al., 2010). Thus far, four waves of GWAS studies for
BMI identiﬁed 32 loci that reached genome-wide signiﬁcance and
unequivocally were associated with BMI in a large meta-analysis
performed by the GIANT (Genetic Investigation of ANtropomet-
ric Traits) consortium (Frayling et al., 2007; Scuteri et al., 2007;
Loos et al., 2008; Willer et al., 2009; Speliotes et al., 2010; Loos,
2012; Mägi et al., 2013). The ﬁrstly identiﬁed locus, FTO (fat mass
and obesity associated gene), has the largest effect on obesity-
susceptibility with obesity at a risk of 1.20 fold. Moreover, the
frequency of the BMI-increasing allele is high in white Europeans
(i.e., 40%). As a consequence, of all 32 BMI-associated loci, the
FTO locus explains the largest proportion of the inter-individual
variation in BMI (0.34%; Speliotes et al., 2010; Loos, 2012).
In this study,we investigated the genetic association of pediatric
BMI using anthropomorphic measures extracted from medical
records in a collection of already genotyped samples from two
large pediatric cohort repositories (CCHMC and CHB) in order
to conﬁrm and identify additional genetic loci.
MATERIALS AND METHODS
STUDY SUBJECTS
Protocols for this study were approved by the Institutional Review
Boards (IRBs) at the institutionswhereparticipantswere recruited.
Only those self-reported to have European ancestry were selected
for study. The anthropometric measurements of height and
weight, as well as age of measurement and gender, were extracted
from the EMR. All enrolled participants with measured weight
and height on the same day were included. All inconsistent or
out of range values were excluded. Out of range was deﬁned
as any height or weight values higher or lower than is consid-
ered biologically possible according to Centers of Disease Control
and Prevention (CDC) growth charts. Children and teens, aged
2 through 19 years old were included based on CDC growth
chart requirements. In addition, three patients with the ICD-9
code for Prader Willi syndrome were excluded from ﬁnal results.
After removing the missing data and outliers, out of a total
of 5,049 individuals, 2860 samples were included in the study.
The demographic distributions of these samples are shown in
Table 1.
GENOTYPING
High throughput single nucleotide polymorphism (SNP) geno-
typing was carried out previously in CCHMC and BCH using
different IlluminaTM or AffymetrixTM platforms (Table 1). Qual-
ity control (QC) of the data was performed before imputation.
In each genotyped cohort, standard QC criteria were met and
SNPs were removed if (a) >10% missing genotyping, (b) out
of Hardy–Weinberg equilibrium (HWE, P < 0.001), or a minor
allele frequency (MAF) <1%. Samples with call rate <98% were
excluded. Principle component analysis (PCA) was performed to
identify outliers and hidden population structure using EIGEN-
STRAT (Price et al., 2006). Based on examination of the scree plot,
the ﬁrst two PCs were retained and used as covariates during the
association analysis in order to adjust for population stratiﬁcation.
PHENOTYPING
We obtained height and weight measurements from EMR in order
to calculate BMI [wt (kg)/(ht(m)2].Whenmultiplemeasurements
were available for a subject, the most recent measurement was
selected and all inconsistentmeasureswere excluded. BMI z-scores
and percentiles were generated using the 2000 CDC growth charts
(study1). These z-scores and percentiles account for the age and
sex differences in BMI throughout childhood. All data for BMI-z
scores (−3 to +3, mean = 0) were scaled to positive value (+4,
1–7, mean = 4) to be used as a quantitative trait for the GWAS
study. In order to assess the burden of increased body weight on
health and estimate the effect size, standard cut-offs were also
used, and the tail BMI distribution was considered as a binary
phenotype (≥95%as case and≤20%as control). For the published
FTO locus, Phenome wide association study (PheWas) was also
performed in which presence or absence of each ICD-9 codes
were considered as binary phenotype. Only ICD-9 codes with
50 or more available samples were included (143 codes) in the
analysis.
STATISTICAL ANALYSIS
Genome-wide association studies analysis was performed by
cohort in PLINK (Purcell et al., 2007) using regression models
and adjusting for age, sex, and the ﬁrst two principal components
(PC). For BMI z-score, the primary analysis was performed using
an additive effect of the minor alleles. However, as previous BMI
associations have reported better model ﬁt with different models,
recessive and dominant models were subsequently evaluated. For
binary phenotypes (dichotomizationof BMIusing a tails approach
and PheWas analyses), allelic association was assessed between
cases and controls by chi-square with 1 degree of freedom (df).
Allelic odds ratio (OR) and 95% conﬁdence intervals (95% CIs)
were obtained. In PheWas analyses, permutation procedure was
performed using sample randomization strategy in which case
1http://www.cdc.gov/healthyweight/downloads/BMI_group_calculator_
English.xls
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Table 1 | Demographic distribution of pediatric cohorts under study.
# Europeans # After removing outliers
and missing values
M/F Mean age (95% CI) Array
CHB 741 613 387/226 13.30 (12.97–13.66) Affymetrix-Axiom
CCHMC 829 696 338/358 10.80 (10.53–11.12) Omni-5
657 405 261/144 7.18 (6.73–7.63) Omni-1
1270 942 589/353 7.32 (7.03–7.62) Illumina-610
1552 204 28/176 13.70 (13.13–14.23) Affymetrix-6
Total 5049 2860 1603/1257 9.8 (8.67–10.85)
and control labels are permuted randomly (×10000) in order to
obtain empirical p values and to correct for multiple testing.
For speciﬁc target regions, imputation-based analyses were
performed using the impute2-Gtool pipeline and the publicly
available 1000 Genomes Project as the reference haplotype panel
composed of 1092 samples (release version 2 of the 1000 Genomes
Project Phase I2 (Howie et al., 2011). For each batch of imputa-
tion runs, the standard Markov Chain Monte Carlo (MCMC)
algorithm implemented in impute-2, was used with the following
threshold criteria (burnin = 10, iteration = 30, and Ne = 20000,
buffer = 250 kb). A threshold of 0.90 for the posterior probability
of each genotype was then applied for genotype calling and con-
version usingGtool. For each imputation run, the overall genotype
concordance rate was more than 95%. Additional post imputation
ﬁlteringwere also implemented to removepoorly imputed variants
with low concordance rate according to the impute-2 standard
protocol (info >0.4; Howie et al., 2011). To graphically display the
results, LocusZoom was used (Pruim et al., 2010).
META-ANALYSES
The results from primary analysis in each cohort were assem-
bled to conduct a ﬁxed effects weighted Z meta-analysis using
Metal (Willer et al., 2010). This approach controls the differences
in phenotype scaling across the studies and weights the signed Z
statistics from each study by its sample size (i.e., weighted sum),
from which a probability is calculated. The program also applies
the genomic control correction to control type I error rates using
summary statistics from each cohort. After QC ﬁltrations in each
cohort (as described above), meta-analyses were performed on
SNP markers that were overlap among all ﬁve cohorts. 92670
SNP markers were in this category. At the next step in order
to allow heterogeneity between cohorts, we applied a minimum
weight of at least 1000 samples for analyses and identify addi-
tional effects. 583824 SNP markers were evaluated in this mode.
We considered genome-wide signiﬁcance thresholds of nominal
p-value <10−8 for any new ﬁndings and report all signiﬁcant
results (p < 0.001) of previously known loci that concurred with
previous publications in terms of strand direction, MAF, and sup-
porting evidence from nearby region. In addition, to describe
the presence or absence of excess variation between cohorts, we
2ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/release/20110521
evaluated the Q-statistic and I2 as a measure of heterogeneity
(Willer et al., 2010).
RESULTS
The demographic distribution of the European ancestry popu-
lation under study (Table 1) shows that the overall mean age
of participants was 9.8 (95% CI = 8.67–10.85) years old with
56% being male. Table 2 shows the estimated prevalence of over-
weight and obesity in these pediatric cohorts with a rate of 28%
overweight (≥85th %ile) and 14% of obesity (≥95th %ile). This
distribution was consistent across all cohorts (Table 2).
Genome-wide analyses were conducted within each cohort.
Associations between SNPs and BMI assumed an additive genetic
model and summary statistics were subsequently used for meta-
analysis using a weighted z-score method. After cleaning the data
by applying our QC criteria, the ratio of the observed to expected
χ2 test statistic (lambda) was λ = 1.007 (Figure 1B). The results
of the meta-analyses of all studies revealed a signiﬁcant signal of
association at 16q12 (Manhattan plot, Figure 1A).
The typed SNP rs8050136 at ﬁrst intron of FTO gene pro-
duced consistent evidence of association in all cohorts with the
best overall result of (P = 1.43 × 10−7, z = 5.26) and with
no heterogeneity between study cohorts (p = 0.77; Figure 1A;
Table 3). In addition, the allele frequencies and strand alignment
are similar across cohorts and consistent with European ancestry.
In consistent with previous publications, when mean of BMI-z
was stratiﬁed by genotype (AA, AC, CC) for SNP (rs8050136),
the additive association with risk allele was observed and it is
Table 2 | Summary of BMI-for-age and prevalence of overweight and
obese children from the CCHMC-BCH cohorts.
Male Female Total
Number of children assessed 1603 1257 2860
Underweight (<5th %ile) 10 9 10
Normal BMI (5th–85th %ile) 62 63 62
Overweight or obese (≥85th %ile)* 28 28 28
Obese (≥95th %ile) 15 12 14
Summary of children’s BMI-for-age and prevalence of overweight and obesity.
*Terminology based on Barlow and the Expert Committee (2007).
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FIGURE 1 | (A,B) Manhattan plot and Q–Q plot of SNP markers used for meta-analyses (genomic inﬂation, λ = 1.007).
Table 3 | Most associated SNPs with BMI-z in CCHMC-BCH pediatric cohorts.
Chr Position Gene SNP Minor allele MAF Z score* P(add) P (rec) PDom Cochran-q I
2 (%)
16 53816275 FTO rs8050136 A 0.39 5.26 1.43e−07 7.34e−08 0.0008 0.71 0
16 53813367 FTO rs17817449 G 0.39 5.02 5.56e−07 5.10e−08 0.001 0.49 0
16 53820527 FTO rs9939609 A 0.39 5.01 6.07e−07 8.53e−08 0.001 0.75 0
16 53800954 FTO rs1421085 C 0.39 4.65 3.45e−06 8.21e−09 0.02 0.61 0
18 57673799 Near MC4R rs12964056 A 0.24 −4.98 6.87e−07 0.0004 4.96e−06 0.95 0
3 42299870 CCK rs8192472 A 0.37 −4.85 1.33e−06 0.0007 0.0002 0.89 0
4 142763570 IL15 rs2099884 T 0.15 4.29 1.27e−05 0.0006 0.0004 0.82 0
2 142855291 LRP1B rs7583748 G 0.10 −3.81 0.0001 0.03 8.08e−005 0.19 0.41
2 644953 TMEM18 rs7561317 A 0.17 −3.17 0.001 0.09 0.02 0.74 0
*The direction of all effect (weighted z scores) are for the minor alleles. The I 2 inconsistency metric was null to small for all of the markers (I 2 = 0–42%).
shown in Figure 2 (risk allele, A). There was 0.4 z-score-unit dif-
ference in mean of BMI-z score between homozygotes with risk
and non-risk genotype in our pediatric cohorts (Figure 2). We
further subdivided all cohorts into two age strata of less than
5 and above 5 years old. In meta-analyses of both strata, the
minor allele (A) was associated additively with a higher BMI
(Figure 2).
Next, we performed imputation-based association followed by
conditional analysis to identify independent association in the
FTO locus.We identiﬁed71SNPs at theﬁrst intronic regionof FTO
that were signiﬁcantly associated with BMI in European ancestry,
all of which were of similar magnitude (Z score 4.4 < z < 5.26,
p-values between 10−7 < p < 10−6) and with high linkage dis-
equilibrium (LD) with each other (r2 > 0.8; Figure 3A). The
haplotype boundaries and recombination rate in this ancestry are
also shown in Figure 3. Indeed, the SNP rs8050136 was in proxy
with other well-known variants in this region including rs9939609
(r2 = 0.98), rs17817449 (r2 = 0.99), rs1421085 (r2 = 0.93) and all
resided in the same haplotype and are associated with obesity in
adults (4–9). Therefore, no independent effect has been identiﬁed.
Table 3 shows the summary of SNP results after regression analy-
ses under additive and recessive models adjusted for age, gender,
and PC. No signiﬁcant difference was observed when the cohort
site is included as another covariate (Data not shown). Of note,
and only in this intron, more than 10 polymorphic indels were
also associated with BMI-z, in particular A/AT at chr16:53822169
(MAF = 36%) and TTTC/T at chr16:53829962 (MAF = 35%;
p = 2.41 × 10−5, p = 8.09 × 10−5, respectively). We noticed a
subtle improvement of overall results using recessive model in our
cohorts (Figure 3B; Table 3). In particular, another published SNP
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FIGURE 2 | Genotypic correlation of FTO-SNP rs8050136 with mean of
BMI-z score. The result further divided by age above and less than 5 years
old respectively. All BMI-z scores (−3 to +3, mean = 0) were transformed
to positive value (+4, 1–7, mean = 4).
rs1421085 generated the best result z =5.782,p(Rec) =8.21×10−9
(Table 2).
Although BMI is a continuous trait, standard cut-offs were also
used to assess the burden of increased body weight on health as
a binary phenotype and estimate the effect size. When the tail
distribution was considered (>95% as case and <20% as con-
trol), an OR of 1.61 (95% CI = 1.31–1.97, p = 4.04 × 10−6)
was detected for the best surrogate marker rs8050136, adjusted by
age, sex, and PC. The strongest effect size was observed using a
recessive model for rs1421085 [(OR = 2.79, 95% CI = 1.89–4.10),
p = 1.83 × 10−7].
When heterogeneity was allowed between cohorts, weaker sig-
nals were also obtained in loci, such as near the MC4R region
(rs12964056, p = 6.87 × 10−7, z = −4.98), cholecystokinin
CCK (rs8192472, p = 1.33 × 10−6, z = −4.85), Interleukin 15
(rs2099884, p = 1.27 × 10−5, z = 4.34), low density lipopro-
tein receptor-related protein 1B [LRP1B (rs7583748, p = 0.00013,
z = −3.81), and near transmembrane protein 18 (TMEM18;
rs7561317, p = 0.001, z = −3.17)], all of which have been pre-
viously reported to be associated with obesity or BMI (Table 3;
4–10). The imputation result for the MC4R region shows multiple
association markers (Figure 3C).
We also performed imputation in additional regions of inter-
est. Of note, one new locus that has not been previously reported
to be associated with BMI, passed the GWAS signiﬁcance level
in our cohorts (p < 1.0E−10−8). The best marker was a rela-
tively infrequent intronic SNP, rs1542829 in the COL6A5 gene
in chromosome 3, with overall MAF of 5% that produced a
p = 4.35 × 10−9, z = 5.89 under an additive model adjusted
for age, gender, and PC. The allele frequency of this marker was
consistent among cohorts and with CEU-Hapmap data, and it
was in HWE. Additional SNP markers in this region, after impu-
tation, produced probabilities at the level of 10−5(Figure 3D). Of
note, the majority of these SNPs had MAF of less than 10% with
less cohesive haplotype boundaries (Figure 3D). When we con-
sidered the tail distribution (>95% as case and <20% as control)
of BMI-z as a binary phenotype, an OR of 2.90 (95% CI = 1.93–
4.34), p = 9.03 × 10−8 was obtained for this marker with MAF
of 9% in cases vs. 3% in controls. Other unreported loci with
suggestive associations to pediatric BMI (10−7 < p < 10−5),
include KCNH5 (rs10136789, p = 4.62 × 10−7, z = 5.05), APOL5
(rs2016586, p = 3.26 × 10−6, z = −4.67), LRRC7 (rs10889850,
p = 1.77 × 10−6, z = −4.78), and GALNT13 (rs12693973,
p = 1.65 × 10−6, z = −4.80).
Finally, using ICD-9 diagnostic codes in our collections, we
have also performed a Phewas study for the best identiﬁed mark-
ers in the FTO locus. In this approach, presence or absence of
each diagnostic ICD-9 code was included as a binary pheno-
type, allelic associations were assessed between cases and controls,
and the ﬁnal results were corrected for multiple testing. By this
approach, a negative association was detected between cases with
hypertrophic cardiomyopathy or valvular structural heart disease
and the FTO common risk alleles (ICD-9 codes = 424.0–424.3
and 425) in a subset of 81 cases and 2259 controls. This effect
remained signiﬁcant after 10000 permutations [p(perm)= 0.0009,
OR = 0.53 (95% CI 0.37–0.77)]. Suggestive positive associations
were also observed between the risk alleles and ICD-9 codes for
impaired glucose tolerance test (ICD-9 = 790.2) and myopia
(ICD-9 = 367.1; p < 0.05), however, this effect did not remain
signiﬁcant after permutation and correcting for multiple testing.
It is noteworthy to mention that in our pediatric cohorts, the
number of patients with diabetes related diagnostic codes (one
of the BMI-related phenotype) was small and not sufﬁcient for
independent analysis.
DISCUSSION
In this study, we evaluated BMI in ﬁve European ancestry pedi-
atric cohorts with available EMR-linked genotyped data from the
CCHMC-BCH eMERGE-II Network site. We successfully utilized
anthropomorphic measures to calculate BMI-for-age percentile,
derived BMI-z scores according to CDC growth charts, performed
quantitative trait locus GWAS study and conducted meta analyses.
The overall adjusted meta-analysis result of 2860 European sam-
ples produced the best signal in the 16q12 genomic region at the
ﬁrst intron of the FTO locus for a cluster of SNPs. The best typed
marker rs8050136 produced [p(Rec) = 7.34 × 10−8), z = 5.26]
and with no heterogeneity between cohorts (p = 0.77). When the
tail distribution was considered (≥95% as case and ≤20 as con-
trol), an OR of 1.61 (95% CI = 1.313–1.965, p = 4.04 × 10−6)
was detected. Notably, this OR estimate in our data was relatively
higher than previous adult studies (OR = 1.2; Loos, 2012). In
any case, considering the effect size (or OR) at the range of 1.2
and the high MAF of the FTO loci (0.40) in Europeans, 700 sam-
ples were sufﬁcient for us to achieve an optimum power of 0.8
with a type 1 error level of 0.05. In fact, genetic variants in the
ﬁrst intron of FTO present as the strongest BMI-associated GWAS
locus in humans. Over the past few years, the association of the
FTO locus has been repeatedly replicated, not only for BMI, but
also for obesity risk, body fat percentage, waist circumference, and
other obesity-related traits, in particular type II diabetes (Scuteri
et al., 2007; Frayling et al., 2007). Recent association with dyslipi-
demia, hypertension, reduced brain volume, Alzheimer’s disease,
and dementia has also been reported that could be confounded
with obesity and vascular complications (Pausova et al., 2009;
Keller et al., 2011).
The functional mechanism of FTO however is still elusive and
is currently the subject of intense interest. It is anAlkB-like, Fe(II)-
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FIGURE 3 | Post imputation results on selected regions. (A) Imputation
results and signal at FTO locus contributing to BMI. SNPs are plotted by
position in a 0.2 Mb window of chromosome 16 against association with
BMI-z (−log10 P -value). The panel highlights the most signiﬁcant SNP in a
meta-analysis using an additive model. Estimated recombination rates
(from HapMap) are plotted in cyan to reﬂect the local LD structure. The
SNPs surrounding the most signiﬁcant SNP (rs8050135), are color-coded
to reﬂect their LD with this SNP (taken from pairwise r2 values from the
HapMap CEU database, www.hapmap.org). Regional plots were
generated using LocusZoom (http://csg.sph.umich.edu/locuszoom).
(B) Regression results at the FTO locus under recessive model, best
marker = rs1421085, p(rec) = 8.21 × 10−9. (C) Imputation results near
the MC4R locus at chromosome 18, is shown. Best marker rs12964056,
p = 6.87 × 10−7, z = −4.98. (D) A new effect at the COL6A5 locus
in chromosome 3. Best marker rs1542829 p = 4.35 × 10−9,
z = 5.889.
and 2-oxoglutarate-dependent nucleic acid demethylase that has
been shown to demethylate 3-methylthymine and 3-methyluracil
in single-stranded DNA and RNA, respectively (Gerken et al.,
2007). A link between FTO demethylase activity and increased fat
mass was suggested by recent animal studies. Notably, homozy-
gous mutant fto−/− mice show postnatal growth retardation and
a signiﬁcant reduction in adipose tissue and lean body mass, an
observation that also was supported by the deleterious muta-
tion Ile367Phe in mouse FTO protein with an impaired activity
from a separate study (Church et al., 2009; Gao et al., 2010). In
both studies, the leanness of fto-deﬁcient mice seems to be the
result of increased energy expenditure and systemic sympathetic
Frontiers in Genetics | Applied Genetic Epidemiology December 2013 | Volume 4 | Article 268 | 6
“fgene-04-00268” — 2013/12/2 — 10:50 — page 7 — #7
Namjou et al. GWAS study for childhood BMI
activation. Interpreting energy expenditure from these results,
however, was challenging because of body composition differ-
ences and growth retardation. Overall, these experimental data
suggest that inactivation of the FTO gene protects from obesity.
On the other hand, mice globally overexpressing FTO are obese,
hyperphagic, and exhibit normal energy expenditure when cor-
rected for lean tissue mass (Church et al., 2010). Most human
studies also report that obesity-predisposing FTO alleles are
associated with increased food intake, but not energy expendi-
ture (Speakman et al., 2008; Haupt et al., 2009). Although the
detailed mechanisms are still not clear, this is suggested to be
the result of increased expression of FTO in humans, due to
cis-regulatory variation in intron 1 of this gene which is con-
sistent with the mouse models, in which decreased levels of
FTO cause a lean body habitus (Zabena et al., 2009; Berulava
and Horsthemke, 2010). Moreover, a positive correlation of
FTO gene expression with other adipocytokine gene expressions,
including leptin, perilipin, and visfatin, has also been shown
(Haupt et al., 2009).
Consistent with previous studies and because of high LD
between FTO intron-1 markers in Europeans (Figure 2), con-
ditional analyses didn’t produce independent effect; however, we
observed a subtle improvement of FTO association using reces-
sive models in comparison to additive models (Figure 1; Table 2).
This effect was unique to the FTO locus, while use of a domi-
nant model was best near the MC4R region (Table 3). Indeed,
between-study variations in regard to the optimal inheritance
model of the FTO polymorphisms have been noticed previously.
In one study, eight differentmeta-analysis results of BMI inwomen
with polycystic ovary syndromes were systematically reviewed
and the recessive model was found to ﬁt best in half of them
and the additive model worked best in the rest (Wojciechowski
et al., 2012). In our pediatrics population in which we had an
enrichment of earlier age of obesity with a prevalence rate of
28%, a recessive pattern may be more relevant in comparison
to the general population. Under this model, another intron-1
marker, rs1421085, produced the best result p(Rec) = 8.21 × 10−9,
z = 5.78 (Table 3; r2 = 0.93 with rs8050136). Indeed, the variant
rs1421085 is particularly interesting. It is located within a highly
conserved element and the risk allele C has been predicted to sub-
stantially reduce binding afﬁnity for CUX1, a transcription factor
implicated in the regulation of FTO (Stratigopoulos et al., 2011;
Peters et al., 2013).
Limited evidence suggests that the cross-sectional FTO asso-
ciation with BMI varies by age. Speciﬁcally, at early ages (up to
5–7 years), the association between common variation at FTO
and BMI appears to be reduced in magnitude (Hardy et al., 2010).
Longitudinal twin studies also suggest that with increasing age loci
such as FTO may be able to exert a greater effect on BMI which
depends on the inﬂuence of shared environmental effect and the
timing of adiposity rebounds (Haworth et al., 2008; Sovio et al.,
2011). In our cohorts when we divide all samples into two strata
of less than 5 and above 5 years old, we didn’t observe any oppos-
ing effect, however a higher magnitude was identiﬁed for strata
above 5 years old (OR = 1.72) (Figure 2). Larger sample size
with detailed longitudinal data would seem to be needed to fully
elucidate this correlation.
Furthermore, in the context of rare and severe phenotypes,
recently, in a large Palestinian Arab consanguineous multiplex
family with nine affected, a homozygous R316Q enzyme inacti-
vating mutation in the FTO gene, resulted in a broad spectrum
of clinical manifestations including severe intrauterine growth
retardation, severe microcephaly, and death from infection before
the age of three (Boissel et al., 2009). Of note, six out of eight
cases had structural heart defect with cardiomyopathy. This would
appear consistent with our unique observation of a negative
association of obesity-predisposing FTO alleles with cardiomy-
opathy [p(corr) = 0.0009, OR = 0.53 (95% CI 0.37–0.77)] that
could result in lower expression of FTO; although further stud-
ies with larger sample sizes are necessary to conﬁrm or refute
this ﬁnding. In fact, to our knowledge, no SNP in intron 1 of
FTO has been previously associated with any trait unrelated to
BMI. Recently, an independent effect at the eighth intron of the
FTO locus has been reported to be associated with melanoma
(GenoMELConsortiumet al., 2013). The bestmarker, rs16953002,
was replicated using 12,313 cases and 55,667 controls of Euro-
pean ancestry in a study conducted by the GenoMEL consortium
(combined P = 3.6 × 10−12, OR = 1.16). Notably, in their
study, none of the BMI related SNPs in intron 1 were associ-
ated with melanoma. Similarly, in our collection, there was no
effect observed at the eighth intron of the FTO gene with BMI
(p = 0.54 for rs16953002, r2 < 0.01 with rs8050136). This suggests
independent functions and genetic risks for FTO that broaden
the existing paradigm and identify distinct pathogenic effects
(GenoMEL Consortium et al., 2013).
In this report, we have supported association in other previ-
ously reported BMI loci, in particular loci near the MC4R region
(rs12964056, p = 6.87 × 10−7, z = −4.98), cholecystokinin
CCK (rs8192472, p = 1.33 × 10−6, z = −4.85), Interleukin 15
(rs2099884, p = 1.27 × 10−5, z = 4.34), low density lipopro-
tein receptor-related protein 1B [LRP1B (rs7583748, p = 0.00013,
z = −3.81)] and near transmembrane protein 18 (TMEM18;
rs7561317, p = 0.001, z = −3.17; Table 2). Because of their lower
effect on BMI and obesity risk (OR ∼1.10, in adult meta-data)
and lower allele frequency, the identiﬁcation of these loci requires
a quadrupling of the sample size in a random population. Finding
all of these loci in our pediatric collections, despite limited sample
size, indicate the enrichment of the genetic signal to noise ratio
given the shorter amount of time that environment has had an
effect.
Additionally, we have detected a new unreported signal at
chromosome 3 (Col6A5) (best SNP is rs1542829, MAF of 5%
p = 4.35 × 10−9, z = 5.89). This marker produced an OR of 2.90
when the tail distributions (>95% as case and <20% as control,
386 cases, and 572 controls) was considered as binary phenotype.
Considering this level of OR (2.90), even with MAF of 5%, 500
samples were sufﬁcient for us to achieve the extraordinary power
(0.99) with a type 1 error level of 0.05. This could be considered as
one of the rare obesity risk loci thatwe expect to detect in these spe-
cial cohorts. The α5-containing collagen VI (Col6A5, COL29A1),
belongs to the class of collagens containing von Willebrand fac-
tor type A domains. These collagens form ﬁlaments with globular
domains containing vWA motifs, which are involved in protein-
ligand interactions for the organization of tissue architecture and
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cell adhesion. Collagen VI is a major extracellular matrix (ECM)
protein with a critical role in maintaining skeletal muscle func-
tional integrity. It has been suggested that type VI collagen is a
ﬁbrotic component that restricts adipose tissue expandability. In
humans, Col6A3 gene expression in adipose tissues was found to
correlate with visceral adipose tissue mass and pro-inﬂammatory
gene expression (Pasarica et al., 2009). Mutations in different fam-
ilies of this gene have also been associated with myopathy and
muscular dystrophy. Recently, it has been shown that COL6A5
is involved in adhesion at myotendinous and dermal–epidermal
junctions (Sabatelli et al., 2012). Different polymorphisms in or
near this gene have been linked to atopic dermatitis and eczema,
but with contradictory reports (Söderhäll et al., 2007; Naumann
et al., 2011). In our cohorts, the number of samples with Atopic
dermatitis and related conditions (ICD-9 = 691) was only 49 with
a trend of association for published SNP rs7629719 (p = 0.14);
adjusting the results based on presence or absence of atopy, didn’t
have any effect on overall BMI associations. A larger sample size
is necessary to further elucidate this coexistent condition and
to determine whether COL6A5 has any role in obesity related
conditions.
Four additional novel loci with homogenous but suggestive
associations (10−7 < p < 10−5) to childhood BMI were also
identiﬁed in this study. These include KCNH5 (rs10136789,
p = 4.62 × 10−7, z = 5.05), a voltage-gated potassium channel
with various function in neurotransmitter regulation, hormone
release, cardiac function, and cell volume; APOL5 (rs2016586,
p = 3.26 × 10−6, z = −4.67), a component of high-density
lipoprotein with a potential role in lipid metabolism; LRRC7
or Densin (rs10889850, p = 1.77 × 10−6, z = −4.78) a core
component of post-synaptic densities andGALNT13 (rs12693973,
p= 1.65x10−6, z =−4.80) a member of the UDP-N-acetyl-alpha-
D-galactosamine and a major enzyme responsible for the synthesis
of O-glycan. Independent cohorts are necessary to conﬁrm these
preliminary suggestive ﬁndings and their importance in childhood
obesity.
Despite the limitations of using an EMR-derived data set for
analysis of secondary phenotypes including errors in data extrac-
tions, discordant time of sampling, and underlying coexistent
conditions of our pediatric cohorts, we demonstrate that a strong
signal, larger than seen in adult populations is detectable. We
have removed all inconsistent data and outliers to the best of
our ability. We have also excluded infants and those less than
2 years old because of the complexity of growth chart pattern
and many potential maternal effects on infants from perinatal
periods. In addition we assessed the distribution of BMI-z in the
whole population with a large sample size as a quantitative trait
rather than attempting to identify limited cases and controls. From
the statistical standpoint, quantitative traits usually are preferred
in meta-GWAS studies because they improve power to detect a
genetic effect and often have a more interpretable outcome (Bush
and Moore, 2012). Furthermore, BMI is a highly heritable trait
in humans and, as mentioned above, up to 70% of the inter-
individual variation in obesity canbe attributable to genetic factors
per se (Maes et al., 1997); therefore, given the strong genetic con-
ﬁrmation described here, indeed, we managed to repurpose the
genotyping data collected for the analyses of another phenotype
and successfully ﬁnd association between the new phenotype and
genotypic data.
In summary, using the EMR-linked genotyped data, we have
conﬁrmed association of several previously known BMI loci, in
particular with the FTO gene [OR of 1.61 (95% CI = 1.31–1.97)].
Our data also support the importance of variants at the FTO locus
in childhood obesity and with saturation of an earlier age of onset,
these data point to a closer functional variant in this locus.
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